These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 37215925

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L, Fang H, Guo F, Yin M, Long H, Weng G.
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
    Chen JH, Wu X, Wang ZM, Liu ZY, He BX, Song WP, Zhang WZ.
    J Thorac Dis; 2023 Mar 31; 15(3):1373-1386. PubMed ID: 37065578
    [Abstract] [Full Text] [Related]

  • 27. Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer.
    Li K, Wang W.
    Front Genet; 2022 Mar 31; 13():981392. PubMed ID: 36313441
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification of N7-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma.
    Ma X, Yang B, Yang Y, Wu G, Ma X, Yu X, Li Y, Wang Y, Guo Q.
    Front Genet; 2022 Mar 31; 13():946845. PubMed ID: 36105111
    [Abstract] [Full Text] [Related]

  • 30. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY, Xiao HN, Zhao ZY, Xiang C, Chen ZY, Wang PX, Xia Y, Yu B, Li H, Xiao T.
    J Cancer Res Clin Oncol; 2023 Sep 31; 149(11):9105-9128. PubMed ID: 37171615
    [Abstract] [Full Text] [Related]

  • 31. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
    Huang Z, Lou K, Liu H.
    Front Genet; 2022 Sep 31; 13():1030275. PubMed ID: 36313442
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
    Peng YL, Dong YF, Guo LL, Li MY, Liao H, Li RS.
    PLoS One; 2023 Sep 31; 18(8):e0289552. PubMed ID: 37535570
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA).
    Cao R, Yuan L, Ma B, Wang G, Tian Y.
    Cancer Cell Int; 2020 Sep 31; 20():276. PubMed ID: 32607061
    [Abstract] [Full Text] [Related]

  • 40. A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma.
    Zhou Z, Zhou Y, Liu W, Dai J.
    Front Genet; 2023 Sep 31; 14():1148430. PubMed ID: 37065485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.